PanGenex Corporation (OTC: PGXC) pursues business opportunities in the dietary supplement industry and works with its subsidiary, Calgenex Corporation, to manufacture topical over-the-counter (OTC) drugs and personal care products specially formulated to help support healthy mineralization and combat the effects of soft tissue calcification and inflammation. The Company manufactures and markets several unique products, including Calci-CLEAR, a three-step program that helps cleanse the body of calcium crystals and keeps new crystals from forming, Omeganol that combines the triglyceride-lowering properties of omega 3s with the cholesterol balancing activity of tocotrienols, and Dermalleve that effectively relieves symptoms of chronic skin diseases such as psoriasis, eczema or dermatitis and allows the body to heal. Increased life expectancy as well as rising interest in self-medication are just some of the factors that are driving this market, and with its innovative products designed to provide tangible health benefits, PanGenex is poised to become a market leader in this strong and growing industry.